0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query qyresearch global psoriatic arthritis treatment market size status forecast 2025.Your search for "" gave back 1533058 results.
In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Rheumatic Disorders...
Catalog:
9Dimen Research
May 2022
Price: USD 3,200.00
The global Musculoskeletal Disorders Therapeutics market size was valued at US$ million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Rheumatic Disorders...
Catalog:
9Dimen Research
February 2020
Price: USD 2,850.00
The biologics used in Anti-inflammatory treatment – abatacept (Orencia), adalimumab (Humira), anakinra (Kineret), etanercept (Enbrel), infliximab (...
Catalog:
LPI
March 2023
Price: USD 3,660.00
An autoimmune disease is a condition arising from an abnormal immune response to a functioning body part. There are at least 80 types of autoimmune...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
An autoimmune disease is a condition arising from an abnormal immune response to a functioning body part. There are at least 80 types of autoimmune...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Highlights The global Arthritic Therapeutic market was valued at US$ 28340 million in 2022 and is anticipated to reach US$ 35210 million by 2029,...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Abatacept (marketed as Orencia) is a drug used to treat autoimmune diseases like rheumatoid arthritis, by interfering with the immune activity of T...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Summary Antipyretic Analgesics and NSAIDs market research report provides the newest industry data and industry future trends, allowing you to...
Catalog:
ICRW
March 2021
Price: USD 2,960.00
Tyrosine Protein Kinase JAK1 - Pipeline Review, H2 2020 Summary Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - JAK1 is a...
Catalog:
Global Markets Direct
July 2020
Price: USD 3,500.00
Summary Antipyretic Analgesics and NSAIDs market research report provides the newest industry data and industry future trends, allowing you to...
Catalog:
ICRW
March 2019
Price: USD 2,960.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) that explicitly targets enzymes responsible for inflammation and pain namely...
Catalog:
LPI
February 2023
Price: USD 3,660.00
